These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of Zhao L; Niu B; Fang J; Pang Y; Li S; Xie C; Sun L; Zhang X; Guo Z; Lin Q; Chen H J Nucl Med; 2022 Jun; 63(6):862-868. PubMed ID: 34556528 [TBL] [Abstract][Full Text] [Related]
4. A comparison of [ Liu N; Wan Q; Wu X; Zhao T; Jakobsson V; Yuan H; Chen X; Zhang J; Zhang W Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1685-1697. PubMed ID: 38246909 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [ Zang J; Wen X; Lin R; Zeng X; Wang C; Shi M; Zeng X; Zhang J; Wu X; Zhang X; Miao W; Xu P; Guo Z; Zhang J; Chen X Theranostics; 2022; 12(16):7180-7190. PubMed ID: 36276644 [TBL] [Abstract][Full Text] [Related]
7. Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy. Pang Y; Zhao L; Fang J; Chen J; Meng L; Sun L; Wu H; Guo Z; Lin Q; Chen H J Nucl Med; 2023 Sep; 64(9):1449-1455. PubMed ID: 37321827 [TBL] [Abstract][Full Text] [Related]
8. Non-invasive visualization of liver fibrosis with [ Song Y; Qin C; Chen Y; Ruan W; Gai Y; Song W; Gao Y; Hu W; Qiao P; Song X; Lv X; Zheng D; Chu H; Jiang D; Yang L; Lan X Eur J Nucl Med Mol Imaging; 2024 Oct; 51(12):3572-3584. PubMed ID: 38850311 [TBL] [Abstract][Full Text] [Related]
9. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144 [TBL] [Abstract][Full Text] [Related]
10. Design, Preclinical Evaluation, and Clinical Translation of Zhao L; Pang Y; Fang J; Chen J; Zhou Y; Sun L; Wu H; Guo Z; Lin Q; Chen H J Nucl Med; 2024 Mar; 65(3):394-401. PubMed ID: 38176714 [TBL] [Abstract][Full Text] [Related]
11. [ Shang Y; Zhang G; Yao X; Lai C; Wang F; Zeng B; Liu E; Yuan H; Cheng Z; Jiang L Mol Imaging Biol; 2024 Aug; 26(4):729-737. PubMed ID: 38987449 [TBL] [Abstract][Full Text] [Related]
12. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571 [TBL] [Abstract][Full Text] [Related]
13. Preclinical Evaluation and a Pilot Clinical Positron Emission Tomography Imaging Study of [ Du X; Gu B; Wang X; Wang X; Ji M; Zhang J; He S; Xu X; Yang Z; Song S Mol Pharm; 2024 Feb; 21(2):904-915. PubMed ID: 38179677 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic Potential of Supplemental Static and Dynamic Röhrich M; Daum J; Gutjahr E; Spektor AM; Glatting FM; Sahin YA; Buchholz HG; Hoppner J; Schroeter C; Mavriopoulou E; Schlamp K; Grott M; Eichhorn F; Heußel CP; Kauczor HU; Kreuter M; Giesel F; Schreckenberger M; Winter H; Haberkorn U J Nucl Med; 2024 Jun; 65(6):872-879. PubMed ID: 38604763 [TBL] [Abstract][Full Text] [Related]
16. Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the Läppchen T; Bilinska A; Pilatis E; Menéndez E; Imlimthan S; Moon ES; Afshar-Oromieh A; Rösch F; Rominger A; Gourni E Molecules; 2024 Jun; 29(13):. PubMed ID: 38999044 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and Preclinical Evaluation of a Novel FAPI-04 Dimer for Cancer Theranostics. Zhong X; Guo J; Han X; Wu W; Yang R; Zhang J; Shao G Mol Pharm; 2023 May; 20(5):2402-2414. PubMed ID: 37015025 [TBL] [Abstract][Full Text] [Related]